Pamlab Announces Agreement for Sale of Business to Nestle Health Science

   Pamlab Announces Agreement for Sale of Business to Nestle Health Science

Acquisition Adds Value to Patients and Healthcare Providers in Brain Health
and Metabolic Health

PR Newswire

COVINGTON, La., Feb. 27, 2013

COVINGTON, La., Feb. 27, 2013 /PRNewswire/ --Pamlab, a specialty biomedical
company taking a personalized nutritional approach with prescription medical
foods for the brain health and metabolic health markets, today announced that
it has signed an agreement to sell its business to Nestle Health Science for
an undisclosed amount. Nestle Health Science aims to develop science-based
nutritional solutions to deliver improved personalized healthcare for people
with chronic medical conditions. This transaction is subject to regulatory
approval.

Pamlab's innovative products, including Metanx^®, CerefolinNAC^®, and
Deplin^®,  have helped address the nutritional management of metabolic issues
associated with diabetic peripheral neuropathy, mild cognitive impairment,
clinical depression respectively, and other diseases and conditions.

"We are excited to join forces with Nestle Health Science, and we share their
commitment to personalized nutrition," said Eric Wingerter, Pamlab President
and Chief Executive Officer. "With their support, we will accelerate the
development and deployment of our innovative nutritional solutions for people
with chronic metabolic and neurologic conditions. We are united by a common
purpose, and a common culture, founded on our passion for patients to make a
difference in people's lives."

"The acquisition of the Pamlab business is aligned with our strategic ambition
to provide science-based nutritional solutions for people with chronic medical
conditions. Pamlab will particularly strengthen our brain health platform and
provide us an additional foothold in metabolic health in the U.S.," said Luis
Cantarell, Nestle Health Science President and Chief Executive Officer. "By
leveraging our nutrition heritage and U.S. operations with Pamlab's proven
expertise in medical foods and strong sales force capabilities, together we
can play a key role in helping to manage certain chronic diseases and improve
the quality of patients' lives," he added.

Pamlab's capabilities strongly support Nestle Health Science's ambition of
pioneering science-based nutritional solutions to deliver improved
personalized healthcare for medical conditions. Pamlab's expertise in
providing unique, science-based solutions to address distinct nutritional
needs in a variety of disease states including diabetes, depression, and mild
cognitive impairment/early memory loss will help accelerate Nestle Health
Science's business ambitions in metabolic health and brain health. In
addition, Nestle Health Science will be able to leverage Pamlab's strong sales
force capabilities and reach to promote science-based personalized nutritional
solutions in the U.S. This transaction will enable customers in the U.S. to
benefit from an expanded range of products and services.

About Pamlab
Pamlab was founded by Sam and Judy Camp in 1987 and is a fully integrated
biomedical company that employs approximately 400 people. Pamlab specializes
in medical foods that are used under the medical supervision of health care
providers to meet the distinct nutritional requirements of patients with
diabetic neuropathy, dementia, depression, high-risk pregnancy and other
medical conditions. Pamlab is committed to improving lives through the
development and commercialization of products that enable physicians to
provide greater individualized patient care. Pamlab's products are marketed
and sold in the U.S., helping patients with diabetic peripheral neuropathy,
dementia, depression, high-risk pregnancy and other medical conditions.
Pamlab's corporate offices are located in Covington, Louisiana. For more
information about Pamlab, please visit www.pamlab.com.

About Nestle Health Science
Nestle Health Science, a wholly-owned subsidiary of Nestle, was formed in
January 2011 to spearhead the development of science-based personalized
nutritional solutions. Building on its core HealthCare Nutrition business, the
company has ambitions to address chronic conditions in the area of
Gastrointestinal Health, Metabolic Health and Brain Health. Nestle Health
Science offers nutritional solutions for people with specific dietary needs
related to illnesses, disease states or the special challenges of different
life stages. Nestle Health Science employs around 3,000 people worldwide and
has its headquarters in Lutry, Switzerland. For more information, visit
www.nestlehealthscience.com.

SOURCE Pamlab

Website: http://www.pamlab.com
Contact: Jim Currie, Media Relations, Pamlab, +1-504-813-4656,
jcurrie@pamlab.com
 
Press spacebar to pause and continue. Press esc to stop.